European Radiology:卷积神经网络在脑转移瘤自动检测中的应用

2022-04-06 shsaosai MedSci原创

利用深度学习技术(如神经网络)算法对脑转移瘤进行自动检测已引入临床应用。

由于脑转移存在与否涉及到分期和治疗计划,因此对于脑转移瘤的准确诊断于确定适当的治疗策略至关重要。例如,全脑放疗是多发转移的标准治疗方法;但对于病灶较小且较少的患者,则考虑采用立体定向放射治疗。因此,术前准确评估病灶的数量、大小以及位置至关重要

近年来,利用深度学习技术(如神经网络)算法对脑转移瘤进行自动检测已引入临床应用。一些研究已经证明了使用各种卷积神经网络(CNN)自动检测脑转移瘤的优势。在强化后的T1加权成像中,增强的血管可能被误诊为转移性肿瘤。因此,人们引入了血管抑制的成像方法来减少假阳性(FPs)的发生有学者提出了一种三维MR序列-VISIBLE技术用于脑转移瘤的检测。VISIBLE同时采集有血管抑制的图像(以下简称 "黑图像")和没有血管抑制的图像("亮图像")。

近日,发表在European Radiology杂志的一研究开发使用CNN和VISIBLE检测脑转移瘤的自动模型,并将其诊断性能与之前的观察者测试进行比较为脑转移瘤快速准确的定量定性及定位提供了技术支持

项回顾性研究纳入了2016年3月至2019年7月用VISIBLE成像的临床怀疑有脑转移的患者。选取有和无血管抑制的图像用于训练现有的CNN(DeepMedic)。使用灵敏度和每个病例的假阳性结果(FPs/case)评估了诊断性能。本研究将CNN模型的诊断性能与12位放射科医生的诊断性能进行了比较。 

本研究将50名在随访中被临床诊断为脑转移的患者(30名男性和20名女性;年龄范围29-86岁;平均63.3±12.8岁;共165个转移病例)用于训练。本研究提出模型的敏感性为91.7%,高于观察者测试(平均±标准差;88.7±3.7%)。模型中的FPs/病例数为1.5,高于观察者测试(0.17±0.09)。 


 60岁的女性,患有肺癌和多个脑转移病变。在黑(a)和亮(b)图像中,显示额叶一个转移瘤(箭头)。其大小约为2毫米。我们的CNN模型在黑(c)和亮(d)图像中准确地检测到这个病灶(箭头)

总之,与放射科医生相比,本研究由VISIBLE和CNN创建的诊断脑转移的模型显示出更高的灵敏度。

原文出处

Yoshitomo Kikuchi,Osamu Togao,Kazufumi Kikuchi,et al.A deep convolutional neural network-based automatic detection of brain metastases with and without blood vessel suppression.DOI:10.1007/s00330-021-08427-2

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1729472, encodeId=fec71e2947288, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Wed Apr 13 21:04:47 CST 2022, time=2022-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2076088, encodeId=041920e60883d, content=<a href='/topic/show?id=8a3b93455ec' target=_blank style='color:#2F92EE;'>#转移瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93455, encryptionId=8a3b93455ec, topicName=转移瘤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3eaf430, createdName=bsmagic9132, createdTime=Thu Jan 12 09:04:47 CST 2023, time=2023-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1336591, encodeId=e2b3133659105, content=<a href='/topic/show?id=424185133f8' target=_blank style='color:#2F92EE;'>#脑转移瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85133, encryptionId=424185133f8, topicName=脑转移瘤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b71f2500114, createdName=1179102698_36768926, createdTime=Thu Apr 07 07:04:47 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1630374, encodeId=ea0316303e481, content=<a href='/topic/show?id=44e0e449217' target=_blank style='color:#2F92EE;'>#神经网络#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74492, encryptionId=44e0e449217, topicName=神经网络)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6ff21497204, createdName=by2016, createdTime=Thu Apr 07 07:04:47 CST 2022, time=2022-04-07, status=1, ipAttribution=)]
    2022-04-13 feather89
  2. [GetPortalCommentsPageByObjectIdResponse(id=1729472, encodeId=fec71e2947288, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Wed Apr 13 21:04:47 CST 2022, time=2022-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2076088, encodeId=041920e60883d, content=<a href='/topic/show?id=8a3b93455ec' target=_blank style='color:#2F92EE;'>#转移瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93455, encryptionId=8a3b93455ec, topicName=转移瘤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3eaf430, createdName=bsmagic9132, createdTime=Thu Jan 12 09:04:47 CST 2023, time=2023-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1336591, encodeId=e2b3133659105, content=<a href='/topic/show?id=424185133f8' target=_blank style='color:#2F92EE;'>#脑转移瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85133, encryptionId=424185133f8, topicName=脑转移瘤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b71f2500114, createdName=1179102698_36768926, createdTime=Thu Apr 07 07:04:47 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1630374, encodeId=ea0316303e481, content=<a href='/topic/show?id=44e0e449217' target=_blank style='color:#2F92EE;'>#神经网络#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74492, encryptionId=44e0e449217, topicName=神经网络)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6ff21497204, createdName=by2016, createdTime=Thu Apr 07 07:04:47 CST 2022, time=2022-04-07, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1729472, encodeId=fec71e2947288, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Wed Apr 13 21:04:47 CST 2022, time=2022-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2076088, encodeId=041920e60883d, content=<a href='/topic/show?id=8a3b93455ec' target=_blank style='color:#2F92EE;'>#转移瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93455, encryptionId=8a3b93455ec, topicName=转移瘤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3eaf430, createdName=bsmagic9132, createdTime=Thu Jan 12 09:04:47 CST 2023, time=2023-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1336591, encodeId=e2b3133659105, content=<a href='/topic/show?id=424185133f8' target=_blank style='color:#2F92EE;'>#脑转移瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85133, encryptionId=424185133f8, topicName=脑转移瘤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b71f2500114, createdName=1179102698_36768926, createdTime=Thu Apr 07 07:04:47 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1630374, encodeId=ea0316303e481, content=<a href='/topic/show?id=44e0e449217' target=_blank style='color:#2F92EE;'>#神经网络#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74492, encryptionId=44e0e449217, topicName=神经网络)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6ff21497204, createdName=by2016, createdTime=Thu Apr 07 07:04:47 CST 2022, time=2022-04-07, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1729472, encodeId=fec71e2947288, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Wed Apr 13 21:04:47 CST 2022, time=2022-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2076088, encodeId=041920e60883d, content=<a href='/topic/show?id=8a3b93455ec' target=_blank style='color:#2F92EE;'>#转移瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93455, encryptionId=8a3b93455ec, topicName=转移瘤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3eaf430, createdName=bsmagic9132, createdTime=Thu Jan 12 09:04:47 CST 2023, time=2023-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1336591, encodeId=e2b3133659105, content=<a href='/topic/show?id=424185133f8' target=_blank style='color:#2F92EE;'>#脑转移瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85133, encryptionId=424185133f8, topicName=脑转移瘤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b71f2500114, createdName=1179102698_36768926, createdTime=Thu Apr 07 07:04:47 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1630374, encodeId=ea0316303e481, content=<a href='/topic/show?id=44e0e449217' target=_blank style='color:#2F92EE;'>#神经网络#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74492, encryptionId=44e0e449217, topicName=神经网络)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6ff21497204, createdName=by2016, createdTime=Thu Apr 07 07:04:47 CST 2022, time=2022-04-07, status=1, ipAttribution=)]

相关资讯

CELL:人类脑部恶性肿瘤单细胞分析

组织驻留和入侵的免疫细胞在TME内的异质性允许我们明确区分胶质瘤和脑转移瘤(BrM)。胶质瘤TME主要是以组织驻留、反应性小胶质细胞为主,而组织侵入性白细胞主要积累在脑转移瘤中。

Lancet oncol:派姆单抗治疗未治疗过的脑转移的非小细胞肺癌的疗效和安全性

Goldberg等人在非小细胞肺癌(NSCLC)或黑素瘤伴未治疗的脑转移患者中开展了pembrolizumab(派姆单抗)的2期试验,以确定PD-1阻滞在中枢神经系统(CNS)中的活性。

Br J Cancer:系统性炎症评分与脑转移瘤患者的生存预后相关

脑转移瘤(BMs)作为常见的实体癌,是一种威胁生命的并发症。

Nat Commun:脑脊液的免疫细胞分析可表征脑转移瘤微环境

脑转移瘤(BrM)是脑部中最常见的肿瘤,是一种破坏性的癌症并发症。

JNNP :接受抗凝治疗的脑转移瘤患者的脑出血研究

脑转移(BM)在晚期实体恶性肿瘤患者中很常见。实体恶性肿瘤患者也易发生静脉血栓栓塞(VTE),包括深静脉血栓形成或肺栓塞,一些研究表明,脑受累患者的VTE发生率较高。低分子肝素抗凝治疗是目前癌症患者V

Radiology:人工智能,实现脑转移瘤的“一站式”检测

脑转移发生在约20%-40%的癌症患者中,且由于治疗手段的不断进步,癌症患者的存活期明显延长,因此发病率可能进一步上升。